34 results
8-K
EX-99.1
ARAV
Aravive Inc
31 Mar 22
Aravive Reports Fourth Quarter and Full Year 2021
4:05pm
. These independent directors strengthen oversight and broaden the Company’s technical capabilities in clinical and business development.
Fourth Quarter and Full Year
8-K
EX-99.1
t18057y6
22 Mar 22
Aravive Appoints Scott Dove, Ph.D., as Chief Operating Officer
4:06pm
8-K
u27 qwh1m0pkp
22 Mar 22
Aravive Appoints Scott Dove, Ph.D., as Chief Operating Officer
4:06pm
8-K
EX-10.1
kf4dq whifcs479zne
10 Nov 20
Entry into a Material Definitive Agreement
7:10am
8-K
EX-1.1
rusb qkzmirm
27 Nov 19
Aravive Announces Proposed Public Offering of Common Stock
4:15pm
8-K
EX-1.1
l5fj8szlapxru
26 Mar 19
Entry into a Material Definitive Agreement
6:07am
8-K
EX-10.2
241rmkgvyt
12 Feb 19
Departure of Directors or Certain Officers
4:20pm
8-K
EX-10.4
xg2p73
12 Feb 19
Departure of Directors or Certain Officers
4:20pm